首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Cancer research

缩写:CANCER RES

ISSN:0008-5472

e-ISSN:1538-7445

IF/分区:22.6/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引12921条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Yingjing Zhang,Pengfei Su,Tian Yu et al. Yingjing Zhang et al.
Immune checkpoint blockade (ICB) has revolutionized cancer treatment, yet its efficacy in gastrointestinal malignancies is often limited by an immunosuppressive tumor microenvironment. In this study, we identified phospholipase C beta 1 (PL...
Sumedha Pareek,Robin D Wright,Riccardo Ballarò et al. Sumedha Pareek et al.
Exercise induces a variety of changes in the tumor microenvironment, with beneficial effects in several tumor types. However, a better understanding of the clinical effects of exercise and mediating mechanisms is needed to maximize the util...
Rachel S Sousa,Shannon N Geels,Claire Murat et al. Rachel S Sousa et al.
The immune system can eradicate cancer, but various immunosuppressive mechanisms active within a tumor curb this beneficial response. However, unraveling the effects of multimodal interactions between tumor and immune cells and their contri...
Jiawei Zou,Kai Xiao,Zexi Chen et al. Jiawei Zou et al.
Spatial transcriptomic analyses provide spatially resolved gene expression data that can provide insights into complex biological processes. However, current spatial transcriptomics approaches remain financially prohibitive and restricted i...
Santiago Garcia Borrego,Sandra Misale Santiago Garcia Borrego
Mutant KRAS inhibition has revolutionized the treatment of lung adenocarcinoma. Unfortunately, responses to this form of targeted therapy are often of limited duration because of the development of resistance. Targeted protein degradation, ...
Santiago Garcia Borrego,Sandra Misale Santiago Garcia Borrego
Mutant KRAS inhibition has revolutionized the treatment of lung adenocarcinoma. Unfortunately, responses to this form of targeted therapy are often of limited duration because of the development of resistance. Targeted protein degradation, ...
Edgar Gonzalez,Jesse Kreger,Yingtong Liu et al. Edgar Gonzalez et al.
High levels of immune suppression are a common intrinsic mechanism of resistance in metastatic breast cancer that calls for developing immunotherapeutic combinations to broaden treatment responses. Histone deacetylase (HDAC) inhibitors can ...
Meenakshi Sudhakaran,Kelly Kersten Meenakshi Sudhakaran
Women who carry a pregnancy to term have long been known to have a reduced lifetime risk of breast cancer, yet the mechanisms underlying this protection remain poorly understood. While parity-induced differentiation and hormonal remodeling ...
Yu Meng,Qian Zhou,Deze Zhao et al. Yu Meng et al.
Induction of ferroptosis is a potential strategy for treating cancer and improving the efficacy of immunotherapy. Ferroptosis is driven by excessive peroxidation of polyunsaturated fatty acid-containing phospholipids, suggesting that microe...
Gabriel Gomis,Claudia Herrero,Saioa Arrieta-Aranzueque et al. Gabriel Gomis et al.
Antibody-drug conjugates (ADCs) show clinical efficacy against several solid malignancies, inducing cytotoxic effects in malignant cells accompanied by changes in the composition of the tumor stroma. The therapeutic effects of some ADCs hav...